Does continuous positive airway pressure therapy improve non-alcoholic fatty liver disease?

Does continuous positive airway pressure therapy improve non-alcoholic fatty liver disease?

Bibliographic Details
Main Authors:	Kohler, M, Stradling, J
Format:	Journal article
Language:	English
Published:	Wiley 2016

Similar Items

Predictors of long-term compliance with continuous positive airway pressure
by: Kohler, M, et al.
Published: (2010)

Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea?
by: Rossi, V, et al.
Published: (2014)

Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.
by: Kohler, M, et al.
Published: (2009)

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients.
by: Robinson, G, et al.
Published: (2006)

TREATMENT OF OBSTRUCTIVE SLEEP-APNEA WITH NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE
by: Stradling, J
Published: (1983)

Brain natriuretic peptide is unchanged after 4 weeks of continuous positive airway pressure therapy.
by: Pepperell, J, et al.
Published: (2006)

NOCTURIA IN OBSTRUCTIVE SLEEP-APNEA - EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE
by: Warley, A, et al.
Published: (1987)

The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial.
by: Rossi, V, et al.
Published: (2012)

Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.
by: Kohler, M, et al.
Published: (2011)

Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea A randomized controlled trial
by: Kohler, M, et al.
Published: (2011)

Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
by: Craig, S, et al.
Published: (2009)

Obstructive sleep apnoea. Evidence for efficacy of continuous positive airways pressure is compelling.
by: Stradling, JR, et al.
Published: (1997)

Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea.
by: Jenkinson, C, et al.
Published: (1997)

The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: A randomised controlled trial.
by: West, S, et al.
Published: (2009)

Predictors Of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial
by: Turnbull, C, et al.
Published: (2015)

Automatic nasal continuous positive airway pressure titration in the laboratory, patient outcomes
by: Stradling, JR, et al.
Published: (1996)

Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes.
by: Stradling, J, et al.
Published: (1997)

Predictors of continuous positive airways pressure usage at six months in minimally symptomatic patients: further data from the MOSAIC trial.
by: Turnbull, C, et al.
Published: (2015)

Withdrawal of continuous positive airway pressure therapy for 2 weeks in obstructive sleep apnoea patients results in increased circulating platelet and leucocyte-derived microvesicles
by: Ayers, L, et al.
Published: (2016)

Withdrawal of Continuous Positive Airway Pressure Therapy for 2 Weeks in Obstructive Sleep Apnoea Patients Results in Increased Circulating Platelet and Leucocyte-Derived Microvesicles.
by: Ayers, L, et al.
Published: (2016)

The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnea syndrome is proven.
by: Davies, R, et al.
Published: (2000)

Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials.
by: Stradling, J, et al.
Published: (2015)

Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing.
by: Davies, R, et al.
Published: (1993)

Is (re)titration of nasal continuous positive airway pressure for obstructive sleep apnoea necessary?
by: Choi, S, et al.
Published: (2001)

The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.
by: Rossi, V, et al.
Published: (2013)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
by: Craig, SE, et al.
Published: (2012)

Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trial.
by: Prudon, B, et al.
Published: (2013)

Effects of Continuous Positive Airway Pressure on Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea: A Systematic Review
by: Susyana Tamin, et al.
Published: (2023-04-01)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
by: Robinson, G, et al.
Published: (2008)

The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea.
by: Ali, N, et al.
Published: (1992)

Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea.
by: Jenkinson, C, et al.
Published: (2001)

Does greater obesity alter the relationship between autoset continuous positive airways pressure (CPAP) and either obstructive sleep apnoea (OSA) severity or the obesity itself?
by: Turnbull, C, et al.
Published: (2015)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
by: Pepperell, J, et al.
Published: (2000)

Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea.
by: Meston, N, et al.
Published: (2003)

Nasal Symptoms in Patients with Obstructive Sleep Apnoea and Their Association with Continuous Positive Airway Pressure Usage
by: Konstantinos Chaidas, et al.
Published: (2022-02-01)

S3 Effect of continuous positive airway pressure on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials
by: Bratton, D, et al.
Published: (2013)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
by: Warley, A, et al.
Published: (1987)

Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial.
by: Siccoli, M, et al.
Published: (2008)